Avandia Tagged Articles

Childhood obesity campaign sparks criticism, concern

Posted: January 6, 2012 Pharmaceutical

An advertising campaign featuring overweight kids telling viewers that “being fat takes the fun out of being a kid,” and “Some diseases aren’t just for adults anymore,” aimed at tackling the issue of childhood obesity, are conjuring up criticism from

New drug could offer more treatment options for type 2 diabetes

Posted: January 1, 2012 Pharmaceutical

French drug maker Sanofi has won approval from European authorities to market the type 2 diabetes drug lixisenatide, which will be sold under the brand name Lyxumia. The Food and Drug Administration (FDA) is currently reviewing the medication for sale

TZD category of diabetes drugs should be taken with caution

Posted: December 20, 2011 Pharmaceutical

People who suffer from type 2diabetes should be wary of a category of medicines used to treat the disorder, as the drugs have been linked to serious complications, according to a report in the Corpus Christi Caller-Times. This category of

Metformin may help protect against diabetes-associated cancers

Posted: December 7, 2011 Pharmaceutical

A common drug used to treat type 2 diabetes may prevent natural and man-made chemicals from stimulating the growth of cancer cells, suggests a new study from Michigan State University (MSU) and South Korea’s Seoul National University. The study looked

Judge considers consolidating Actos lawsuits

Posted: December 6, 2011 Pharmaceutical

Judges are considering whether to consolidate tens of thousands of lawsuits filed in the United States against Japanese drug maker Takeda over its type 2 diabetes drug Actos. The lawsuits claim the drug causes bladder cancer. The claims are backed

FDA moves back review date for new drug containing Actos

Posted: December 4, 2011 Pharmaceutical

Japanese drug maker Takeda Pharmaceuticals Co. will have to wait even longer to hear if the Food and Drug Administration (FDA) will approve its two experimental diabetes medications. The decision was expected by Jan. 25, 2012, but federal regulators have

Diabetes drugs sent thousands to emergency room last year

Posted: December 1, 2011 Pharmaceutical

Diabetes drugs such as Actos and Avandia are among the four categories of medications responsible for two-thirds of emergency room visits in people over the age of 65, according to a new study published in the New England Journal of

Diabetes rate expected to skyrocket over next 20 years

Posted: November 17, 2011 Product Liability

The number of adults with diabetes is expected to skyrocket to at least one in 10 – or an estimated 552 million people – by 2030, according to the International Diabetes Federation. The advocacy group said the figures were conservative

Profits of diabetes drug Actos drop amid bladder cancer scare

Posted: November 10, 2011 Product Liability

Japan pharmaceutical company Takeda has announced a nosedive in first-half operating profits in the wake of new bladder cancer warnings on its top-selling type 2 diabetes pill Actos. The company posted a 4.8 percent drop in profits despite an April-September

Prediabetes is a diagnosis to take seriously

Posted: November 9, 2011 Product Liability

More than 90 percent of an estimated 60 million Americans are on the verge of getting type 2 diabetes but are completely unaware that they are at risk, according to HealthWomen.org. Many of these people have no symptoms, and many